Advocating for a world where intellectual
property law serves the public interest.

Prosecco Wars: An Aperitif for new Australia-EU trade talks

“The prosecco issue is one of the many skirmishes we could see if the European community seeks to expand the protection of GI to include a wider range of wine regions, as well as food and foodstuffs under the proposed new trade agreement,” Professor Matthew Rimmer said.

Intellectual Property and Digital Trade in the Age of Artificial Intelligence and Big Data

CEIPI/ICTSD Publications Series, Issue 5: This new issue ... edited by Xavier Seuba, Christophe Geiger and Julien Pénin, elaborates on changes in modes of innovation, production and commercialisation of innovation, which are central in current discussions and relate closely to intellectual property law and competition. The chapters of this volume feed the debate, identify the central aspects and may be

I-MAK & Delhi Network of Positive People File Opposition to Prevent AbbVie Patent Grant on Hepatitis C Treatment

[I-MAK & Delhi Network of Positive People] On July 21, the Initiative for Medicines, Access & Knowledge (I-MAK) and the Delhi Network of Positive People (DNP+) filed a pre-grant patent opposition with the Indian Patent Office in Delhi against pibrentasvir (PIB), part of the drug combination that forms AbbVie’s hepatitis C (HCV) product, Mavyret. Filed on the eve of the

South Africa’s Proposed Copyright Fair Use Right Should Be a Model for the World

[Sean Flynn, Michael W. Carroll, Peter Jaszi, Ariel Katz, Leandro Mendonça, Diane Peters, and Allan Rocha de Souza] Copyright laws the world over are under massive pressure to reform to fit the digital environment. One key area often in need of reform is in the exceptions to copyright that enable the digital practices. Without exceptions, common practices may be illegal,

I-MAK Comments to the U.S. Department of Health and Human Services on the Trump Administration “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

[Initiative for Medicines, Access & Knowledge]… I-MAK’s years of research and successful legal challenges show that all too often, drug manufacturers hold unmerited patents on old science. This enables a few manufacturers to corner the market on entire diseases, artificially inflating the price of treatment, and blocking access to affordable generic drugs for decades. We believe America is facing two

The First Rule of Copyright Reform: Don’t Mess With Free Speech and Net Neutrality

... What distinguishes the European copyright reform experience from others and what lessons might be learned for future efforts around the world? One takeaway is that there are presently two kinds of copyright reforms. The first involves a conventional balancing of copyright interests, typically framed as creator rights on the one hand and users’ rights on the other. Ensuring both